EW Insider Trading
Insider Ownership Percentage: 1.29%
Insider Buying (Last 12 Months): $49,729.20
Insider Selling (Last 12 Months): $18,709,727.98
Edwards Lifesciences Insider Trading History Chart
This chart shows the insider buying and selling history at Edwards Lifesciences by year and by quarter.
Skip ChartChart Data in Insider Trading History Table
Edwards Lifesciences Share Price & Price History
Current Price: $71.29
Price Change: ▼ Price Decrease of -0.06 (-0.08%)
As of 03/25/2025 04:58 PM ET
Edwards Lifesciences Insider Trading History
Edwards Lifesciences Institutional Trading History
Data available starting January 2016
Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Read More on Edwards Lifesciences
Today's Range
Now: $71.29
52 Week Range
Now: $71.29
Volume
6,112,449 shs
Average Volume
4,624,092 shs
Market Capitalization
$41.91 billion
P/E Ratio
10.23
Dividend Yield
N/A
Beta
1.12
Who are the company insiders with the largest holdings of Edwards Lifesciences?
Edwards Lifesciences' top insider shareholders include:
- Larry L Wood (Insider)
- Jean-Luc M Lemercier (VP)
- Michael A Mussallem (Director)
- Michael A Mussallem (CEO)
- Bernard J Zovighian (CEO)
- Kieran Gallahue (Director)
- Donald E Bobo Jr (VP)
- Steven R Loranger (Director)
- Catherine M Szyman (VP)
- Scott B Ullem (CFO)
- Daveen Chopra (VP)
- Heisz Leslie Stone (Director)
- Daniel J Lippis (VP)
- Robert WA Sellers (SVP)
Learn More about top insider investors at Edwards Lifesciences.
Who are the major institutional investors of Edwards Lifesciences?
Which institutional investors are selling Edwards Lifesciences stock?
Within the previous quarter, EW stock was sold by these institutional investors:
- Alliancebernstein L.P.
- CIBC Private Wealth Group LLC
- Ameriprise Financial Inc.
- Voloridge Investment Management LLC
- Legal & General Group Plc
- Jane Street Group LLC
- National Pension Service
- American Century Companies Inc.
In the previous year, company insiders that have sold Edwards Lifesciences company stock include:
- Larry L Wood (Insider)
- Jean-Luc M Lemercier (VP)
- Michael A Mussallem (Director)
- Michael A Mussallem (CEO)
- Bernard J Zovighian (CEO)
- Kieran Gallahue (Director)
- Donald E Bobo Jr (VP)
- Steven R Loranger (Director)
- Catherine M Szyman (VP)
Learn More investors selling Edwards Lifesciences stock.
Which institutional investors are buying Edwards Lifesciences stock?
During the previous quarter, EW stock was bought by institutional investors including:
- Norges Bank
- Jennison Associates LLC
- Vanguard Group Inc.
- Assenagon Asset Management S.A.
- Raymond James Financial Inc.
- Marshall Wace LLP
- Wellington Management Group LLP
- Seilern Investment Management Ltd